77
43
Growth Score
-8 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
597810
Edenbridge is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products.
Patrick Chu: President & Co-Founder
About the Company
Edenbridge is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products.
The company's goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare
market. Founded in 2008, launched its first product in February 2010 and currently sell its commercial products through every major channel of the U.S. prescription pharmaceutical supply chain. In addition, the company has a robust product development pipeline that includes ANDAs and 505(b)(2)s, and has successfully developed, filed, and received FDA approval for several products.
